Intuitive Machines, Inc. — Form 8-K Summary
Reporting event: January 28, 2024; filed January 30, 2024. The filing reports a material definitive agreement and unregistered equity issuances related to the repayment of a credit line.
Business Context and Transaction
Intuitive Machines, LLC, a subsidiary of Intuitive Machines, Inc., had access to a credit line of up to $10.0 million from Pershing LLC, supported by guarantees and collateral from Ghaffarian Enterprises, LLC, an affiliate of Dr. Kamal Ghaffarian.
Under a January 28, 2024 letter agreement, Ghaffarian Enterprises agreed to contribute cash to the Company and its subsidiary to repay the outstanding credit-line obligations. The repayment was completed on January 29, 2024, and the Credit Line was repaid in full.
Financial and Capitalization Effects
- The contribution amount was the lesser of $10.0 million and the amount required to satisfy the repayment obligation. The filing does not provide a clear final cash contribution amount.
- The Company issued 3,487,278 shares of Class A common stock to the guarantor.
- The Company also issued Series A and Series B warrants, each covering up to 4,150,780 shares, exercisable at the holder’s election for Class A common stock, Class C common stock, or a combination.
- For Class A common stock, the warrants have an exercise price of $2.57 per share. For Class C common stock, the exercise price is $0.0001 per share.
- The Series A warrant is immediately exercisable and expires January 29, 2029. The Series B warrant is immediately exercisable and expires July 29, 2025.
- Intuitive Machines, LLC issued corresponding unit warrants to the guarantor and received mirror warrants and common units from the Company to maintain the Company’s ownership structure.
- The filing provides no revenue, profit, margin, operating cash flow, cash balance, or other broader financial metrics.
Material Changes Versus the Prior Period
- The previously outstanding Credit Line was repaid in full, removing the reported obligation to the lender.
- The transaction resulted in the issuance of common stock and potentially dilutive warrants to an affiliate of Dr. Kamal Ghaffarian.
- The transaction was reviewed and approved by the Company’s independent conflicts committee under its related-person transaction policy.
Guidance, Outlook, Risks, and Unusual Items
- The filing contains no revenue or earnings guidance and no broader operating outlook.
- The principal unusual item is the repayment of debt through a related-party cash contribution in exchange for equity and warrants.
- Future exercise of the warrants could materially dilute existing stockholders. The filing does not quantify the total potential dilution across all classes and corresponding OpCo warrants.
- The securities were issued in unregistered transactions pursuant to Section 4(a)(2) of the Securities Act.
- The filing text states that the OpCo Series B Mirror Warrant expires July 25, 2025, while the related Series B warrant expires July 29, 2025; investors should verify the governing exhibit because this date appears inconsistent.
Key Facts for Investor Verification
- Verify the exact cash contribution and the amount of the Credit Line outstanding immediately before repayment.
- Review the Letter Agreement and all warrant forms for exercise mechanics, settlement provisions, transfer restrictions, and anti-dilution terms.
- Confirm the number of shares or units issuable upon exercise of each warrant and the resulting maximum potential dilution.
- Verify the apparent discrepancy in the expiration date of the OpCo Series B Mirror Warrant.
- Assess the related-party nature of the transaction and the conflicts committee’s approval process.